Juho Jalkanen
Has grant
Chief Development Officer
FinlandResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Juho Jalkanen is the Chief Development Officer at Faron Pharmaceuticals Ltd in Finland. His research focuses on the association between aortic calcification and cytokine levels in patients with peripheral artery disease, as well as the prolonged systemic inflammatory response syndrome after cardiac surgery. Through his work, he contributes significantly to the understanding of cardiovascular health and therapeutic development.
Recent Grants
Grant: Close
PURE ASO
Open Date: 2014-11-01
Close Date:
Grant: Close
PURE ASO
Open Date: 2013-10-01
Close Date:
Grant: Close
PURE ASO
Open Date: 2012-01-01
Close Date:
Articles (2)
Year:
2024
Year:
2024
Collaborators (3)
Dan Laukka
University of Turku
Jenni Aittokallio
Helsinki University Hospital
Tuomas Kiviniemi
Associate Professor
University of Turku
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.